Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 51543-39-6
2. (s)-flurbiprofen
3. (s)-(+)-2-fluoro-alpha-methyl-4-biphenylacetic Acid
4. (s)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanoic Acid
5. S-flurbiprofen
6. (2s)-2-(2-fluorobiphenyl-4-yl)propanoic Acid
7. Flurbiprofen, (s)-
8. (s)-2-(2-fluorobiphenyl-4-yl)propanoic Acid
9. Bts 24332
10. Bts-24332
11. Tt-063
12. J5zzk9p7mx
13. (2s)-2-(3-fluoro-4-phenylphenyl)propanoic Acid
14. (s)-2-fluoro-alpha-methyl-4-biphenylacetic Acid
15. Chembl435298
16. Chebi:42446
17. Esflurbiprofen (jan)
18. Esflurbiprofen [jan]
19. (s)-2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic Acid
20. Esflurbiprofene
21. Esflurbiprofeno
22. Esflurbiprofenum
23. Sfpp
24. Smr000471846
25. Esflurbiprofene [french]
26. Esflurbiprofenum [latin]
27. (s)-(+)-flurbiprofen
28. Esflurbiprofeno [spanish]
29. Unii-j5zzk9p7mx
30. Esflurbiprofen [inn:ban]
31. Flurwood
32. Urbifen
33. (+)-flurbiprofen
34. Flp
35. Einecs 257-263-1
36. Flurbiprofen-(s)-(+)
37. Esflurbiprofen [inn]
38. Zinc323
39. Mls001066337
40. Mls001333207
41. Mls001333208
42. Schembl505817
43. Gtpl9420
44. Esflurbiprofen [who-dd]
45. (s)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanoicacid
46. Dtxsid201316678
47. Hms2232e18
48. Hms3649p05
49. Hms3884i06
50. Bcp24046
51. Bdbm50172479
52. Mfcd00866152
53. Nsc685700
54. S1679
55. Akos016844131
56. Ccg-266907
57. Nsc-685700
58. As-78108
59. Hy-15123
60. Nci60_030810
61. Nci60_030811
62. Db-008733
63. Cs-0003779
64. Sw202926-2
65. A21120
66. D10254
67. Sr-01000946685
68. (s)-(+)-2-fluoro-?-methyl-4-biphenylacetic Acid
69. Sr-01000946685-1
70. Q27104495
71. (s)-(+)-2-fluoro-.alpha.-methyl-4-biphenylacetic Acid
72. (2s)-2-(2-fluoro-[1,1'-biphenyl-4-yl])propanoic Acid
73. (s)-2-fluoro-.alpha.-methyl-4-biphenylacetic Acid
Molecular Weight | 244.26 g/mol |
---|---|
Molecular Formula | C15H13FO2 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 244.08995782 g/mol |
Monoisotopic Mass | 244.08995782 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 286 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
M - Musculo-skeletal system
M02 - Topical products for joint and muscular pain
M02A - Topical products for joint and muscular pain
M02AA - Antiinflammatory preparations, non-steroids for topical use
M02AA29 - Esflurbiprofen
(s)-flurbiprofen has known human metabolites that include 4-hydroxy-S-flurbiprofen.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Market Place
ABOUT THIS PAGE
A Esflurbiprofen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Esflurbiprofen, including repackagers and relabelers. The FDA regulates Esflurbiprofen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Esflurbiprofen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Esflurbiprofen supplier is an individual or a company that provides Esflurbiprofen active pharmaceutical ingredient (API) or Esflurbiprofen finished formulations upon request. The Esflurbiprofen suppliers may include Esflurbiprofen API manufacturers, exporters, distributors and traders.
click here to find a list of Esflurbiprofen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Esflurbiprofen DMF (Drug Master File) is a document detailing the whole manufacturing process of Esflurbiprofen active pharmaceutical ingredient (API) in detail. Different forms of Esflurbiprofen DMFs exist exist since differing nations have different regulations, such as Esflurbiprofen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Esflurbiprofen DMF submitted to regulatory agencies in the US is known as a USDMF. Esflurbiprofen USDMF includes data on Esflurbiprofen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Esflurbiprofen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Esflurbiprofen suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Esflurbiprofen as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Esflurbiprofen API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Esflurbiprofen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Esflurbiprofen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Esflurbiprofen NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Esflurbiprofen suppliers with NDC on PharmaCompass.
Esflurbiprofen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Esflurbiprofen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Esflurbiprofen GMP manufacturer or Esflurbiprofen GMP API supplier for your needs.
A Esflurbiprofen CoA (Certificate of Analysis) is a formal document that attests to Esflurbiprofen's compliance with Esflurbiprofen specifications and serves as a tool for batch-level quality control.
Esflurbiprofen CoA mostly includes findings from lab analyses of a specific batch. For each Esflurbiprofen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Esflurbiprofen may be tested according to a variety of international standards, such as European Pharmacopoeia (Esflurbiprofen EP), Esflurbiprofen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Esflurbiprofen USP).
LOOKING FOR A SUPPLIER?